Bioengineering approaches for patient-specific analysis of placenta structure and function

Adrienne K. Scott, Daniella M. Fodera, Patrick Yang, Abigail Arter, Amelia M. Hines, Samyuktha S. Kolluru, Samantha G. Zambuto, Kristin M. Myers, Ulugbek S. Kamilov, Anthony O. Odibo, Michelle L. Oyen

Research output: Contribution to journalArticlepeer-review

Abstract

The leading cause of perinatal mortality is fetal growth restriction (FGR), defined as in utero fetal growth below the 10th percentile. Insufficient exchange of oxygen and nutrients at the maternal-fetal interface is associated with FGR. This transport occurs through the vasculature of the placenta, particularly in the terminal villi, where the vascular membranes have a large surface area and are the thinnest. Altered structure of the placenta villi is thought to contribute to decreased oxygen exchange efficiency, however, understanding how the three-dimensional microstructure and properties decrease this efficiency remains a challenge. Here, a novel, multiscale workflow is presented to quantify patient-specific biophysical properties, 3D structural features, and blood flow of the villous tissue. Namely, nanoindentation, optical coherence tomography, and ultrasound imaging were employed to measure the time-dependent material properties of placenta tissue, the 3D structure of villous tissue, and blood flow through the villi to characterize the microvasculature of the placenta at increasing length scales. Quantifying the biophysical properties, the 3D architecture, and blood flow in the villous tissue can be used to infer changes in maternal-fetal oxygen transport at the villous membrane. Overall, this multiscale understanding will advance knowledge of how microvascular changes in the placenta ultimately lead to FGR, opening opportunities for diagnosis and intervention.

Original languageEnglish
Pages (from-to)154-163
Number of pages10
JournalPlacenta
Volume166
DOIs
StatePublished - Jun 13 2025

Bibliographical note

Publisher Copyright:
© 2024 The Authors

Funding

Work on this project is supported by Wellcome Leap as part of the In Utero Program (MLO), the NIH T32 Postdoctoral Training Grant in Regenerative Medicine (AKS; T32EB028092), the Washington University in St. Louis Collaboration Initiation Grant in Women's Health Technologies, and the NIH T32 Clinical Outcomes Research Training Program in Female Lower Urinary Tract Disorders (SGZ: T32DK120497). The authors would also like to acknowledge Madison Landeros for her technical assistance optically clearing and imaging tissue. Additionally, the authors would like thank Dr. Mathew Bersi for kindly sharing the OCT microscope in his laboratory. Lastly, we would also like to thank Susan Boss-Miller in the OB-GYN Clinical Laboratory at Washington University in St. Louis for collecting patient placenta samples.

FundersFunder number
Wellcome Leap
National Institutes of Health (NIH)T32EB028092
National Institutes of Health (NIH)
Washington University in St. LouisT32DK120497
Washington University in St. Louis

    Keywords

    • Doppler ultrasound
    • Fetal growth restriction
    • Nanoindentation
    • Optical coherence tomography
    • Placenta
    • Villi

    ASJC Scopus subject areas

    • Reproductive Medicine
    • Obstetrics and Gynecology
    • Developmental Biology

    Fingerprint

    Dive into the research topics of 'Bioengineering approaches for patient-specific analysis of placenta structure and function'. Together they form a unique fingerprint.

    Cite this